Hysteroscopic Polypectomy
Malcolm G. Munro MD, FRCSC, FACOG
KEY POINTS
- Endometrial polyps may be present in up to 25% of all women, regardless of symptoms.
- There are a number of factors that place women at increased risk for endometrial polyps that include obesity, age and administration of selective estrogen receptor modulators.
- About 75% of reproductive aged women with endometrial polyps experience AUB that usually is intermenstrual bleeding.
- Approximately 50% of those postmenopausal women with endometrial polyps have no symptoms.
- Endometrial polyps may contribute to infertility, but the evidence is far from clear
- Blind removal of endometrial polyps should be avoided whenever possible as there appear to be an increased rate of complications such as uterine perforation and a higher rate of polyp persistence or recurrence.
- There exists some evidence that electrosurgical removal of polyps is associated with a reduced risk of recurrence than mechanical transection with hysteroscopic scissors.
- Electromechanical morcellators may have some advantages over electrosurgical techniques, including faster operating time and less procedure related pain. Comparative data on recurrence rates are not yet available.
- Polypectomy has been demonstrated to improve AUB symptoms but the role of polypectomy in improving fertility outcomes is unclear
Your Hysteroscopic Polypectomy ToolBOX
Generic
- Endoscopic camera
- Television monitor
- Light source (250+ Watts)
- Light Cables
- Fluid management system
- Connecting tubing
- Appropriate media to technique
- Materials for local anesthesia (if applicable)
- Tissue forceps for specimens
- Formalin media in transportation container
Operative Hysteroscope - Mechanical OR Electromechanical
- 12-15ᴼ foreoblique hysteroscope
- Continuous flow operative sheath with 5-7 Fr operative channel (compatible with hysteroscope)
- 5-6 Fr Scissors
- 5-7 Fr Grasping Forceps
- Alternate - Manual or Motor Driven electromechanical tissue removal device and appropriate hysteroscope
Operative Hysteroscope - Electrosurgical
- 12-15ᴼ foreoblique hysteroscope
- Continuous flow operative sheath with 5-7 Fr operative channel (compatible with hysteroscope)
- 5 Fr bipolar RF hysteroscopic needle
- Electrosurgical generator/unit (ESU) compatible with hysteroscopic needle
- Footpedals for generator
- Connecting cables - electrode to ESU
- 0.9% N Saline media
Resectoscopic
- 12-15ᴼ foreoblique hysteroscope
- Bipolar (preferred) or monopolar resectoscope
- Loop electrode
- Electrosurgical generator/unit (ESU) compatible with resectoscope
- Footpedals for generator
- Connecting cables - electrode to ESU
- 0.9% N Saline media (bipolar systems) OR Low viscosity media (suggest 5% mannitol) for monopolar systems
NOTE: These equipment lists do not include laboratory materials for transferring specimens to the pathology laboratory
The finding of endometrial polyps is common for women suffering from AUB, infertility, recurrent pregnancy loss and postmenopausal bleeding. Relatively simple surgical treatments are effective both for confirming the diagnosis and for treating the symptoms. The increase in pelvic imaging with transvaginal ultrasound (TVUS), and, to some extent sonohysterography, asymptomatic endometrial polyps are frequently identified.
BACKGROUND
Prevalence and Pathogenesis
Endometrial polyps are pedunculated or sessile lesions that arise from the endometrium and, to a variable degree, protrude into the endometrial cavity. Histologically, and visible by ultrasound, they typically solitary but frequently multiple, ranging in size from microscopic to lesions of many centimetres.. Such polyps can manifest in women of any age, but while they are usually benign, a small minority are premalignant or malignant(1, 2).
Whereas endometrial polyps are common, their pathogenesis is poorly understood. They are known to originate from the basalis layer of the endometrium and comprise of glands, stroma and blood vessels (3, 4). Their attachment to the endometrium varies morphologically ranging from narrow pedicle giving a pedunculated appearance or alternatively, to a broader area that results in a sessile phenotype. Regardless of their macroscopic appearance all endometrial polyps include a consistent spectrum of histological features that includes a central core of irregular glands, surrounding dense stroma, thick walled vessels, and a surface epithelium identifiable on three sides(3, 4).
While the pathogenetic mechanisms that result in endometrial polyps are not clear, there appears to be an imbalance between local mitotic activity and apoptosis that regulates normal endometrial proliferation, Estrogen exposure has been implicated in the pathogenesis of endometrial polyps (5-8).
Whereas the most significant correlation for the presence of endometrial polyps is increasing age, there are a number of other risk factors including obesity, hypertension, co-existing cervical polyps, endometriosis and uterine leiomyomas(1, 2, 9-18). Retrospective and prospective studies have provided data demonstrating that endometrial polyps are found more commonly in women with a BMI of >30 a circumstance associated with increased peripheral aromatization of androgens, particularly to estrone (9, 14, 15).
There is also an apparent relationship between pharmacologic agents with estrogenic activity and the risk of endometrial polyps. Tamoxifen, a selective estrogen receptor modulator (SERM), is the drug most consistently demonstrated to be contributory, likely due to its weak estrogenic properties that can act on the endometrium, where the mechanism may be related to apoptosis inhibition (1, 19-23). A similar mechanism is suspected to be active for tibolone, another SERM that has been be associated with an increased risk for the development of endometrial polyp formation (24).
Unlike the case for SERMs, it is less clear that ovarian hormone replacement therapy increases the risk of developing endometrial polyps. The available evidence is mixed as some studies suggest the risk to be increased(11, 25) (26, 42) while others have demonstrated no such relationship (26-29). The role of progestins may be protective, perhaps related to their well-established anti-estrogenic activity and have shown to reduce the impact of tamoxifen, particularly using an intrauterine levonorgestrel releasing system (30).
Since many, if not most endometrial polyps are asymptomatic, the actual prevalence is unknown, although available evidence suggest that as many as 25 % of women in the general population may have these lesions(3, 4). It is apparent that endometrial polyps are found more often in women with AUB symptoms, compared to those with normal menstrual bleeding(9). And women who present with AUB have a wide prevalence of polyps ranging from 10-40 % (2, 9, 11, 12, 19, 31). Then incidence pf polyps increases with age in premenopausal populations but it is not clear if the prevalence declines postmenopausally(1, 2, 9, 10).
While there is no universally accepted classification system, using histological features, endometrial polyps can be classified as follows[Mazur, 2005 #192]:
1. Proliferative/hyperplastic
2. Functional
3. Atrophic
4. Mixed (endometrial-endocervical)
5. Adenomyomatous
6. Malignant
Clinical Significance
It is important to remember that many, if not most, endometrial polyps are probably asymptomatic(6, 32) a circumstance that should give the clinician pause before ascribing the patient’s symptoms – be they AUB, infertility, recurrent pregnancy loss or postmenopausal bleeding. For the premenopausal woman, endometrial polyps are most clearly associated with intermenstrual bleeding as opposed to the symptom of heavy menstrual bleeding (2, 9, 10, 31). It has been suggested that premenopausal women are less likely to be asymptomatic, but it is unclear if these studies have been based on rigorous evaluation of all of the potential contributors to the AUB experienced by the patient.
Spontaneous Regression
One of the challenges when we start imaging individuals and finding abnormalities like polyps is that we don’t know their natural history, which for polyps has been studied only in a limited manner. However, the investigators that did look at this in the context of a small prospective study identified a spontaneous regression of about 27% with polyp size being a major determinant (32). More than one group of investigators has shown that when polyps are at least 1.5 cm in maximum diameter they are less likely to regress than smaller polyps(32, 33) and episodes of heavy bleeding may be a predictor for the passage of polyps(33).
Abnormal Bleeding in Pre- and Postmenopausal Women
When endometrial or endocervical polyps cause abnormal bleeding one mechanism is suspected to be related to stromal congestion within the polyp, a circumstance that leads to venous stasis and necrosis, typically at the apex of the lesion (34). Another theory postulates theories variable expression of gonadal steroid hormone receptors that contribute to an altered response that results in tissue breakdown and related bleeding (6). The available evidence shows no relationship between the number, size or location of the polyps and presence of AUB(51)(35).
While it is difficult to perform large scale population studies investigators have suggested that 56% of postmenopausal women with endometrial polyps experience abnormal bleeding (12, 36, 37). Other data evaluating women for other conditions, suggest that bleeding is far less common (38). A population study from Denmark evaluating women aged 20 to 74 years even reported that AUB less frequently found amongst women with polyps compared with those without sonographic evidence of their presence (11).
Infertility
Endometrial polyps are commonly found in women with infertility(39, 40) with a reported prevalence that is as high as 32%(41). While this sounds high, some studies show a similar prevalence of endometrial polyps in women without infertility, a circumstance that begs determine what, if any, relationship there between endometrial polyps and infertility.
An approach that could be used to answer this question is to evaluate the impact of polypectomy on infertile women. A randomized trial compared expectant management to hysteroscopic polypectomy in 215 infertile women with endometrial polyps about to undergo intrauterine insemination(IUI)(42, 43). The cohort randomized to hysteroscopic polypectomy was twice as likely to become pregnant than those in the control cohort whose polyps were managed without excision. Similarly, a prospective, comparative but non randomized trial of 171 women with endometrial polyps demonstrated that hysteroscopic polypectomy improved IUI results(44). However, the issue remains clouded as two other nonrandomized comparative studies demonstrated no benefit to hysteroscopic polypectomy (45, 46). In one of these studies, evaluating the results of embryo transfer following in vitro fertilization, showed that removing polyps less than 1.5 cm in maximum diameter had no impact(46).
Of course, it is possible that some polyps will have an adverse impact on fertility while others will not. There are a number of potential mechanisms whereby fertility could be adversely impacted by endometrial polyps that include both mechanical interference and local molecular expressions that could impair either sperm transport, embryo implantation or both. A number of candidates have been identified including increased levels of glycodelin(41), aromatase(42), inflammatory markers (43) and reduced levels of HoxA-10 and HoxA-11(44). HoxA-10 and -HoxA-11 messenger RNA are molecular markers associated with endometrial receptivity. To this time, we have been unable to find studies comparing these expressions prior to and after polypectomy.
Malignancy
The overwhelming majority of endometrial polyps are benign, but hyperplasia and malignancy occur in up to 13% (2, 44-49). It appears that the risk of malignancy is highest in those postmenopausal women who have symptoms, particularly postmenopausal bleeding and is much lower in premenopausal women (50). In addition to the risks of increasing age and menopausal status there are other correlates including polyp size > 15mm(46, 47) and a record of tamoxifen use(19, 22, 51). Both atypical hyperplasia and endometrial carcinoma may originate from endometrial polyps, with the two most common pathological categories being endometrioid and serous papillary carcinoma (52, 53).
TVUS with color-flow or power Doppler has the potential to increase the sensitivity and specificity for the diagnosis of malignant polyps, but publications to date have not been encouraging (54-58). There exist newer techniques including three-dimensional (3D) ultrasonography and contrast-enhanced ultrasonography (CEUS) that may improve the accuracy of Doppler examination of tumor vascularization (59) however all should be considered experimental at this time.
DIAGNOSIS
For most women, the diagnosis of endometrial polyps follows presentation to the gynecologist with symptoms of either abnormal uterine bleeding in the reproductive years, or postmenopausal bleeding unrelated to the cyclical use of postmenopausal estrogen and progestin therapy. As discussed, premenopausal women will typically have random bleeding between menses. Of course, this is difficult to discern if indeed the woman has an ovulatory disorder with inherent variation in cycle and period length and duration. Although endometrial polyps are confirmed by histopathological examination, there exist a number of ancillary techniques including TVUS ultrasound, transvaginal sonohysterography using either saline or gel and hysteroscopy. The postmenopausal woman with bleeding and an endometrial polyp will usually have an endometrial echo complex thickness of more than 4 mm. The gynecologist with access to transvaginal ultrasound is encouraged to evaluate women in the office and to liberally use sonohysterography to augment the performance of sonographic imaging.
The TVUS appearance varies somewhat with the polyp’s phenotype and can be impacted on when in the menstrual cycle the study is performed. If possible, TVUS is best performed in the early proliferative phase following completion of the menstrual period when the endometrium is relatively thin, a circumstance that optimizes image quality and minimizes the chance of misdiagnosis with late follicular or luteal phase when the endometrium is at its thickest(60). Pedunculated endometrial polyps typically have an echogenic pattern with a discrete and regular outline, that can appear separate from the adjacent or surrounding endometrium often accompanied by a thin hyperechoic halo (61). Endometrial polyps often include sonolucent cystic spaces created by fluid that originates from the columnar elements of the polyp (62). Broad based polyps are often termed “sessile” and often have a more varied, and subtle nonspecific appearance that is often misperceived as endometrial thickening (63).
The accuracy of simple TVUS varies substantially with the skill and experience of the examiner a circumstance that contributes to equally variable data; sensitivity from 19-96%; specificity of 53-100% (64). Sonohysterography, which is TVUS with the addition of saline or gel contrast somewhat dramatically improves the consistency of sonographic diagnosis of endometrial polyps(2, 65-69). Several studies have reported that sonohysterography is equivalent to hysteroscopy for the diagnosis of endometrial polyps in both premenopausal and postmenopausal women with AUB (66, 70-73).
Ultimately, endometrial polyps are diagnosed and confirmed to be benign by histopathological examination. Blind endometrial sampling, be it with a catheter or curret, no longer has a role in confirming that endometrial polyps are benign. Consequently both the diagnosis and treatment of endometrial polyps is by hysteroscopically-directed excision with histopathological examination.
MANAGEMENT OF ENDOMETRIAL POLYPS
Once a presumptive endometrial polyp, or polyps, have been suspected or diagnosed based on imaging, the approach to management will vary based on a number of factors. These include symptoms, the desire for fertility, the perceived risk of malignancy and the physician’s access to procedural equipment. There are a number of options that can be considered including expectant, medical interventions and surgical excision. Surgical removal of endometrial polyps, regardless of location and type anesthesia, while considered to be low-risk, is not a no-risk procedure and appropriate counseling of the woman is essential.
Expectant Management
As imaging techniques are applied to more and more individuals, including those without symptoms, the chance of identifying lesions that may not have clinical significance rises, and the chance for adverse events becomes a consideration. Consequently, there is a role for expectant management of endometrial polyps in the presence of one or more of three circumstances. First, and as described previously in this section, women with a polyp less than 10mm in diameter on sonographic assessment have a chance of spontaneous regression that is almost 27% over a period of 12 months. Second, the chance of malignancy is low in premenopausal women and in asymptomatic postmenopausal individuals who have an TVUS based EEC <11 mm. Third, those with minimal or no symptoms will not benefit symptomatically from polypectomy, so if they also fit the other criteria they as well are candidates. Some clinicians will suggest that small polyps be followed for up to a year, reassessing the value of removal at that time.
Medical Management
The evidence supporting medical management of endometrial polyps is somewhat tenuous. The use of GnRH agonists has been evaluated but while symptoms are suppressed while on therapy, they tend to return following discontinuation [Vercellini, 1994 #105]. The intrauterine system containing 52 mg of levonorgestrel (LNG-IUS52) has been evaluated in a well-designed comparative trial in women that lasted over four years that demonstrated fewer polyps in the LNG-IUS treated group(74). While this is a preventative trial, it didn’t demonstrate activity in patients with known polyps.
Blind Removal
Given the availability of hysteroscopy, including the opportunity to perform many procedures in an office or clinic environment, there is no longer a role for blind polypectomy. This includes the process of making the diagnosis hysteroscopically and using blind techniques to remove the polyp. Not only is blind excision frequently ineffective there is documented perforation rate of about 1%, sometimes with disastrous consequences when there is related bowel or vascular injury. Available evidence suggests that blind techniques such as “D & C” result in complete removal of endometrial polyps in about 15% of women, a number that reaches about 40% if polyp forceps are used blindly (76-80). Hysteroscopically directed polypectomy, on the other hand, is associated with low complication rates and much higher rates of complete excision (12, 81-84). Collectively the intrauterine endoscopic approaches to endometrial polypectomy are the recommended surgical techniques for this pathology.
Hysteroscopically Directed Polypectomy
Mechanical: Scissors and Graspers
Simple transaction and extraction is generally the most cost effective technique for relatively small or pedunculated and soft polyps that have a minimum diameter comparable with the inside diameter of the cervical canal. Most small, and many larger polyps can be transected at their base with sharp scissors and then removed using tenacious grasping forceps. The diameter of the polyp or polyp fragment should be such that it is extractable through the cervix considering its dilation. Care should be taken to transect the polyps as close to the basalis as possible to minimize the risk of recurrence, a risk that may be lower with electrosurgical technique(86).
Once the hysteroscope is positioned, and the scissors advanced into the endometrial cavity, a useful technique is partial transaction, leaving the polyp attached to the cervical canal or endometrium by a small strand. This allows the instruments to be switched so that the polyp can be easily detached with appropriate grasping forceps. Then, the polyp is brought into proximity with the distal tip of the hysteroscopic system and the entire assembly extracted from the endometrial cavity through the cervical canal. It can help to turn off the inflow of distension media for extraction, one method to reduce the chance of dislodgement from the forceps. If there are more than one polyp this technique can be compromised if small transected vessels bleed rendering the distending media opaque. In such instances other techniques should be considered or the procedure can be completed at a later date.
Resectoscopic Polypectomy
A monopolar, or, preferably, a bipolar radiofrequency (RF) resectoscope can be fitted with a loop electrode and used to transect polyps at their base. The ESU settings will vary based upon the system used and the diameter of the loop electrode. So, the surgeon should be familiar with the specifics of the system in use.
Once transected, the lesions can be captured between the resectoscope’s distal end and the retracted electrode whereupon the entire system, including the polyp, can be removed turning down the media inflow to minimize the risk of dislodgement. Alternatively, a separate grasping instrument can be used to remove each piece, but this generally involves refitting the system with a bridge or using another assembly, a circumstance that can increase procedure time and patient discomfort if performed under local anesthesia.
A potential advantage of this technique is the ability to use the loop electrode to deeply transect the base of the polyp, an approach that may reduce the risk of recurrence. Indeed there is evidence from a comparative study of 240 women that the use of energy does reduces the risk of recurrence; 0% in the RF group and 15% in the women who had scissors and grasping forceps technique for removal of their polyps (86). There are also disadvantages with the use of the resectoscope, that is generally of a larger diameter than operative hysteroscopes or many electromechanical systems – although the OD of some systems is now down to 15 French. The use of monopolar RF resectoscopes offers a greater risk of complications related to media and current diversion that have fortunately been eliminated with bipolar systems that function in saline media. With this and other RF techniques it is important to minimize electrosurgical injury a circumstance that has particular importance with multiple polyps. In such instances, either a staged procedure (multiple sessions) or mechanical techniques may be more appropriate options.
Bipolar RF Needles
Another RF approach is the use of bipolar needles that can be used with the 5 Fr operative channel hysteroscopic systems that are generally of smaller OD than resectoscopes. The needle can be used to dissect, transect and even morcellate the polyp, but like scissors-based dissection requires grasping forceps for removal of polyps. The electrosurgical unit settings are generally specific to the instrument so one cannot provide specific guidance in this regard. Because bipolar instruments function in – even require - saline as distension media, there is a decreased risk of hyponatremia and its sequellae compared to systems that use electrolyte free media (30, 88). The advantage of these bipolar needles is that they can relatively easily bivalve or trivalve a polyp otherwise too large to remove through the cervix and do so in a relatively bloodless fashion because of the electrocoagulation effect. Disadvantages of these systems are the cost – not only of the base unit, but also of the needles that are typically, not always single use designs.
Electromechanical Hysteroscopic Morcellation Systems
The endoscopic electromechanical morcellator and extraction systems were originally designed for use in orthopedics and were modified for use in hysteroscopic surgery in the last 20 years. Their utility for endometrial polypectomy is grounded in the relatively easy learning curve and short operating time because the design is somewhat agnostic to polyp size and number. The devices largely eliminate the need for switching instruments and, consequently, at least for larger or multiple polyps results in fewer removals and reinsertions of instruments through the cervix and decreased risk of cervical laceration and systemic fluid absorption (88, 89).
Their general use and function is described in the section on equipment and supplies. Once the device is positioned in the endometrial cavity, the “window” or fenestration is brought into proximity with the polyp and activated. This usually results in the polyp being quickly morcellated and aspirated. The specimen is captured in a tissue trap that is in line with the aspiration/extraction channel of the system. There may be value in gently pushing fenestration against the attachment of the polyp to the endometrium to resect the stalk or base as close as possible to the basalis of the endometrium.
There is comparative evidence regarding this technique. A multicenter randomized trial allocated 121 women with polyps to either hysteroscopic electromechanical morcellation and extraction or RF resectoscopic resection in an ambulatory setting. The electromechanical technique was associated with a shorter operative time, removal of a greater proportion of polyps, reduced procedure-related pain and greater acceptability to patients than resectoscopic polypectomy (90). Another randomized trial designed to evaluate resident training randomized 60 women to either hysteroscopic electromechanical morcellation or RF electrosurgical resection demonstrating reduced operating time with the electromechanical technique, and, again a minimal apparent learning curve (91).
One of the major issues with these devices is their cost. In most instances they have been developed as single use instruments with exorbitant costs set to facilitate office surgery in otherwise expensive hospital environments. Fortunately, less expensive manually activated systems are becoming available and reusable systems promise to substantially reduce the per case costs while maintaining the other advantages of the technique.
POSTPROCEDURE CARE AND MANAGEMENT
In general, post procedure care is straightforward. Patients can return to their normal preprocedure activities, even on the day of the procedure, a circumstance that is relatively easily achieved when the polypectomy has been performed under local anesthesia without systemic narcotics or anxiolytics. Nevertheless, the patient should be advised that some spotting or light bleeding can be anticipated. There is no particular evidence to guide the resumption of sexual intercourse, but we generally suggest that a couple of days is allowed to pass.
The circumstance is different with infertility as questions arise regarding trying to become pregnant spontaneously or when to resume assisted reproductive techniques that include intrauterine insemination and embryo transfer.
Although the evidence linking hysteroscopic polypectomy to IVF-ET success rates is conflicting, there has been investigation regarding the appropriate timing of ET following polypectomy. In a nonrandomized study of 487 patients, there was no difference when ET was performed after 1, 2-3, or more than 3 subsequent cycles in the rates of implantation (42.4%, 41.2%, 42.1%); clinical pregnancy (48.5%, 48.3%, 48.6%), spontaneous pregnancy loss (4.56%, 4.65%, 4.05%) and live birth rate (44.0%, 43.6%, 44.6%) (92).
VIDEOS
Electrosurgical polypectomy with an RF loop electrode and a resectoscope
Mechanical polypectomy with scissors
Electromechanical Myomectomy - Complex polyp left cornu.
REFERENCES
1. Anastasiadis PG, Koutlaki NG, Skaphida PG, Galazios GC, Tsikouras PN, Liberis VA. Endometrial polyps: prevalence, detection, and malignant potential in women with abnormal uterine bleeding. Eur J Gynaecol Oncol. 2000;21(2):180-3.
2. Reslova T, Tosner J, Resl M, Kugler R, Vavrova I. Endometrial polyps. A clinical study of 245 cases. Arch Gynecol Obstet. 1999;262(3-4):133-9.
3. Mazur MT, Kurman RJ. Polyps. In: Mazur MT, Kurman RJ, editors. Diagnosis of endometrial biopsies and curettings A practical approach. 2nd ed. New York: Springer Science and Business Media Inc; 2005.
4. Mutter GL, Nucci MR, Robboy SJ. Endometritis, metaplasias, polyps and miscellaneous changes. In: Robboy SJ, Mutter G, L., Prat J, BEntley RC, Russell P, Anderson MC, editors. Robboy’s Pathology of the Female Reproductive Tract: Churchill Livingstone - Elsevier; 2009.
5. Lopes RGC, Baracat EC, de Albuquerque Neto LC, Ramos JFD, Yatabe S, Depesr DB, et al. Analysis of estrogen- and progesterone-receptor expression in endometrial polyps. Journal of Minimally Invasive Gynecology. 2007;14(3):300-3.
6. Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol. 2005;48(2):312-24.
7. Sant'Ana de Almeida EC, Nogueira AA, Candido dos Reis FJ, Zambelli Ramalho LN, Zucoloto S. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Maturitas. 2004;49(3):229-33.
8. Stewart CJ, Campbell-Brown M, Critchley HO, Farquharson MA. Endometrial apoptosis in patients with dysfunctional uterine bleeding. Histopathology. 1999;34(2):99-105.
9. Clevenger-Hoeft M, Syrop CH, Stovall DW, Van Voorhis BJ. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstet Gynecol. 1999;94(4):516-20.
10. Van Bogaert LJ. Clinicopathologic findings in endometrial polyps. Obstet Gynecol. 1988;71(5):771-3.
11. Dreisler E, Stampe Sorensen S, Ibsen PH, Lose G. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol. 2009;33(1):102-8.
12. Nagele F, O'Connor H, Davies A, Badawy A, Mohamed H, Magos A. 2500 Outpatient diagnostic hysteroscopies. Obstet Gynecol. 1996;88(1):87-92.
13. Nappi L, Indraccolo U, Di Spiezio Sardo A, Gentile G, Palombino K, Castaldi M, et al. Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps?.
14. Onalan R, Onalan G, Tonguc E, Ozdener T, Dogan M, Mollamahmutoglu L. Body mass index is an independent risk factor for the development of endometrial polyps in patients undergoing in vitro fertilization. Fertil Steril. 2009;91(4):1056-60.
15. Oguz S, Sargin A, Kelekci S, Aytan H, Tapisiz OL, Mollamahmutoglu L. The role of hormone replacement therapy in endometrial polyp formation. Maturitas. 2005;50(3):231-6.
16. Coeman D, Van Belle Y, Vanderick G, De Muylder X, De Muylder E, Campo R. Hysteroscopic findings in patients with a cervical polyp. Am J Obstet Gynecol. 1993;169(6):1563-5.
New Paragraph
New Paragraph
New Paragraph
New Paragraph
New Paragraph
New Paragraph
New Paragraph
New Paragraph